The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

Huma Therapeutics has been granted Class II clearance from the FDA ... Device (SaMD) disease management platform, dramatically expanding the range of services it can deliver. Class II approval ...